288 related articles for article (PubMed ID: 15613455)
1. Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus.
Zierau O; O'Sullivan J; Morrissey C; McDonald D; Wünsche W; Schneider MR; Tenniswood MP; Vollmer G
Endocr Relat Cancer; 2004 Dec; 11(4):823-30. PubMed ID: 15613455
[TBL] [Abstract][Full Text] [Related]
2. The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model.
Vollmer G; Schneider MR
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):103-15. PubMed ID: 8809192
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue.
Wünsche W; Tenniswood MP; Schneider MR; Vollmer G
Int J Cancer; 1998 May; 76(5):684-8. PubMed ID: 9610726
[TBL] [Abstract][Full Text] [Related]
4. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
6. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix induces hormone responsiveness and differentiation in RUCA-I rat endometrial adenocarcinoma cells.
Vollmer G; Ellerbrake N; Hopert AC; Knauthe R; Wünsche W; Knuppen R
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):259-69. PubMed ID: 7696147
[TBL] [Abstract][Full Text] [Related]
8. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
9. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of estrogen- and antiestrogen-induced uterine complement component C3 expression by ICI 164,384.
Galman MS; Sundstrom SA; Lyttle CR
J Steroid Biochem; 1990 Jul; 36(4):281-6. PubMed ID: 2391957
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.
Huynh HT; Pollak M
Cancer Res; 1993 Dec; 53(23):5585-8. PubMed ID: 8242606
[TBL] [Abstract][Full Text] [Related]
12. Hormonal activity of combinations of genistein, bisphenol A and 17beta-estradiol in the female Wistar rat.
Schmidt S; Degen GH; Seibel J; Hertrampf T; Vollmer G; Diel P
Arch Toxicol; 2006 Dec; 80(12):839-45. PubMed ID: 16639590
[TBL] [Abstract][Full Text] [Related]
13. Estrogenic activity of griffonianone C, an isoflavone from the root bark of Millettia griffoniana: regulation of the expression of estrogen responsive genes in uterus and liver of ovariectomized rats.
Wanda GJ; Starcke S; Zierau O; Njamen D; Richter T; Vollmer G
Planta Med; 2007 Jun; 73(6):512-8. PubMed ID: 17486534
[TBL] [Abstract][Full Text] [Related]
14. Functions of estrogens and anti-estrogens in the rat endometrial adenocarcinoma cell lines RUCA-I and RUCA-II.
Schütze N; Kraft V; Deerberg F; Winking H; Meitinger D; Ebert K; Knuppen R; Vollmer G
Int J Cancer; 1992 Dec; 52(6):941-9. PubMed ID: 1459735
[TBL] [Abstract][Full Text] [Related]
15. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
Hyder SM; Stancel GM; Chiappetta C; Murthy L; Boettger-Tong HL; Makela S
Cancer Res; 1996 Sep; 56(17):3954-60. PubMed ID: 8752163
[TBL] [Abstract][Full Text] [Related]
16. The putative tumor suppressor deleted in malignant brain tumors 1 is an estrogen-regulated gene in rodent and primate endometrial epithelium.
Tynan S; Pacia E; Haynes-Johnson D; Lawrence D; D'Andrea MR; Guo JZ; Lundeen S; Allan G
Endocrinology; 2005 Mar; 146(3):1066-73. PubMed ID: 15564322
[TBL] [Abstract][Full Text] [Related]
17. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Dipippo VA; Powers CA
J Pharmacol Exp Ther; 1997 Apr; 281(1):142-8. PubMed ID: 9103491
[TBL] [Abstract][Full Text] [Related]
19. A potent specific pure antiestrogen with clinical potential.
Wakeling AE; Dukes M; Bowler J
Cancer Res; 1991 Aug; 51(15):3867-73. PubMed ID: 1855205
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens.
Heikaus S; Winterhager E; Traub O; Grümmer R
J Mol Endocrinol; 2002 Oct; 29(2):239-49. PubMed ID: 12370124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
